tykhr
sign in
free sign up
Halozyme Therapeutics Inc
Biotechnology
Healthcare
HALO
127 M shares
NASDAQ US
traded
23 Sep 2025
listed
no
open
78.79
52 week high
78.28
high
79.50
52 week low
0.00
low
77.46
growth
30.94 %
previous Close
78.28
P/E ratio
market cap
7.27 B
div yield
0
usd
Jun 2025
qoq
revenue
0.00 %
net incoming
0.00 %
eps
0.00 %
0.00 %
eps surprise
-100.00 %
net profit margin
0.00 %
-44.00 %
operating incoming
0.00 %
net change in cash
0.00 %
cash on hand
0.00 %
cost of revenue
0.00 %
top